Evidence map›Paper›PMID 42515601›Full record

ArticleViruses2026

First Ecuadorian Pediatric Case of Multisystem and Neurological Involvement Associated with Influenza A-H5N1 Virus-Case Report.

Frances Fuenmayor, Santiago Chávez, María de Los Ángeles Costta, Mateo Carvajal, Denisse Benítez, Rommel Guevara, Erika Muñoz, Paúl Cárdenas, Marisol Carrillo, Marcelo Guerrero and 1 more

Abstract readCase Reports
In one paragraph

Article in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Frances FuenmayorBaca Ortiz Pediatric Hospital, Quito 170523, Ecuador.
Santiago ChávezSchool of Medicine, Universidad de las Américas, Quito 170124, Ecuador.
María de Los Ángeles CosttaBaca Ortiz Pediatric Hospital, Quito 170523, Ecuador.ORCID 0000-0003-3336-4954
Mateo CarvajalInstitute of Microbiology, COCIBA, Universidad San Francisco de Quito, Quito 170901, Ecuador.
Denisse BenítezInstitute of Microbiology, COCIBA, Universidad San Francisco de Quito, Quito 170901, Ecuador.
Rommel GuevaraInstitute of Microbiology, COCIBA, Universidad San Francisco de Quito, Quito 170901, Ecuador.
Erika MuñozInstitute of Microbiology, COCIBA, Universidad San Francisco de Quito, Quito 170901, Ecuador.
Paúl CárdenasInstitute of Microbiology, COCIBA, Universidad San Francisco de Quito, Quito 170901, Ecuador.ORCID 0000-0001-9626-4489
Marisol CarrilloIntensive Care Medicine, Pontifical Catholic University of Ecuador, Quito 170525, Ecuador.
Marcelo GuerreroIntensive Care Medicine, Pontifical Catholic University of Ecuador, Quito 170525, Ecuador.
Melanie OrellanaSchool of Medicine, Universidad de las Américas, Quito 170124, Ecuador.ORCID 0009-0006-3710-1480

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Influenza A (H5N1) is a highly pathogenic zoonotic virus with a human fatality rate of approximately 60%. Pediatric cases and associated neurological manifestations remain poorly documented in Latin America. This report describes the first confirmed Ecuadorian pediatric case of H5N1-associated encephalitis and multisystem organ failure in a previously healthy 9-year-old female following direct contact with infected poultry. The clinical course was characterized by an atypical initial presentation of bilateral periorbital edema and headache, progressing to acute encephalitis, cerebral ischemia, flaccid tetraplegia, central diabetes insipidus, and refractory septic shock. Diagnostic confirmation was achieved via nasopharyngeal RT-PCR, with additional RT-PCR and sequencing performed on cerebrospinal fluid, which identified conserved influenza A M1/M2 gene fragments, while laboratory markers-including marked elevations in IL-6, ferritin, and CRP-indicated a severe hyperinflammatory state. Management involved an intensive multidisciplinary approach utilizing oseltamivir, intravenous immunoglobulin, modulated-dose corticosteroids, desmopressin, and mechanical ventilation. Despite a severe clinical course, the patient achieved a favorable recovery, with a Glasgow Coma Scale score of 15/15 at discharge and only partial residual paresis and left hypoacusia as sequelae. This landmark case provides rare evidence of H5N1 neuroinvasion in a pediatric patient and demonstrates that timely detection combined with aggressive immunotherapy and antiviral treatment can improve survival. Furthermore, it underscores the critical necessity for strengthened regional molecular surveillance and clinical training to recognize atypical presentations of emerging zoonoses in Latin America, especially in cases involving contact with sick poultry.

Indexed as

Encephalitis, ViralInfluenza A Virus, H5N1 SubtypeInfluenza, HumanMultiple Organ FailureAnimalsAntiviral AgentsChildEcuadorFemaleHumansOseltamivirPoultryAntiviral AgentsOseltamivircase reportinfluenza A H5N1neurological complicationsoseltamivirpediatricsviral encephalitis

Identifiers

PMID42515601
PMCPMC13431621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.